反応式
[NH:1]1[CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1.C([O-])([O-])=O.[K+].[K+].[F:13][C:14]1[CH:19]=[CH:18][C:17]([CH:20]([C:27]2[CH:32]=[CH:31][C:30]([F:33])=[CH:29][CH:28]=2)[O:21][CH2:22][CH2:23][CH2:24][CH2:25]Cl)=[CH:16][CH:15]=1.C(OCC)(=O)C>CN(C=O)C>[F:13][C:14]1[CH:19]=[CH:18][C:17]([CH:20]([C:27]2[CH:28]=[CH:29][C:30]([F:33])=[CH:31][CH:32]=2)[O:21][CH:22]([N:1]2[CH2:6][CH2:5][NH:4][CH2:3][CH2:2]2)[CH2:23][CH2:24][CH3:25])=[CH:16][CH:15]=1参加物
実験手順
Piperazine (4.31 g, 50 mmol) was dissolved in 40 mL of anhydrous DMF and stirred with K2CO3 powder (2.76 g, 20 mmol) and KI (100 mg, 0.6 mmol) for 0.5 h. To this turbid solution, 1-[bis(4-fluorophenyl)methoxy]-4-chlorobutane (2, 1.55 g, 5 mmol) in 10 mL of DMF was added slowly. The reaction mixture was stirred for 72 h at 60°-70°. The turbid reaction Ore was poured into 200 mL of ethyl acetate, washed with sat NaCl solution (60 mL×5), dried over MgSO4 and evaporated to dryness. The crude oil was applied to a silica gel column for purification. Elution with CHCl3:MeOH (93:7) afforded the desired mono-alkylated product 3 (540 mg, 1.5 mmol, 30%) as a slightly yellow oil. 1H NMR (CDCl3): δ 1.55-1.69 (4H, m), 2.31 (2H, t, J=7.5), 2.39 (4H, br s), 2.88 (4H, t, J=4.8), 3.43 (2H, t, J=6.0), 5.28 (1H, s), 6.98-7.02 (4H, m), 7.25-7.29 (4H, m). mp (bis oxalate salt): 215°-218° C. Anal. C25H30N2O9F2) C, H, N.
後処理
- customThe turbid reaction Ore
- washwashed
- dry with materialdried over MgSO4
- customevaporated to dryness
- customThe crude oil was applied to a silica gel column for purification
- washElution with CHCl3:MeOH (93:7)
出典と根拠
- ORDレコード
- ord-a5072b0b32084764b708de00394f8f43
- 出典データセット
- uspto-grants-2012_02
- 特許番号
- US08114379B2
関連ノート
読み込み中…